Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Hypo-Fractionated Radiation Therapy (HRT) for Localized Prostate Cancer

NCT01677845 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT01677845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01677845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Hypo-Fractionated Radiation Therapy (HRT) for Localized Prostate Cancer
Lead sponsor
NYU Langone Health
Phase
Phase 1
Overall status
Terminated
Start date
May 31, 2012
Completion date
August 25, 2017
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer